Los Angeles Capital Management LLC Denali Therapeutics Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 22,222 shares of DNLI stock, worth $474,884. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,222
Previous 27,940
20.47%
Holding current value
$474,884
Previous $813,000
44.4%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding DNLI
# of Institutions
245Shares Held
120MCall Options Held
91.1KPut Options Held
78.4K-
Black Rock Inc. New York, NY13.2MShares$282 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$263 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$257 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$210 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$117 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.87B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...